As the aging population increases, article authors predict there will be a rising number of patients presenting with degenerative spine changes and cervical myelopathy at various stages. The article seeks to summarize current knowledge gaps and limitations in the evidence for future research, such as:
• The need for unified nomenclature referring to CSM
• The need to specify the incidence of myelopathy
• Prevalence of ossification of the posterior longitudinal ligament
• The need to explore safety and efficacy of neuroprotection and neuroreparative pharmacological strategies
• Optimization of patient management with minimal symptoms
• Development of improved disease screening tools
The article’s lead author is Michael Fehrling, MD, of Toronto Western Hospital.
More Articles on Spine Surgery:
Where Should the Spine Industry’s Attention Be Focused Right Now?
Will SGR Repeal Happen This Year? NASS Weighs In
Want Happier Spine Patients? 5 Approaches to Care
